Baidu
map

肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

2017 ISRNM共识声明：血液透析治疗期间饮食

2017-12-20 国际肾营养和代谢学会 J Ren Nutr. 2018 Jan;28(1):4-12.

血液透析饮食

营养状况不良和蛋白质浪费在维持性血液透析患者中很常见，并且与不良结局相关。血液透析治疗期间提供食物，盘餐，快餐和/或口服营养补充可以改善营养状况，也可以减少炎症的发生。本文主要内容涉及血液透析治疗期间有关饮食的相关内容。

中文标题：

2017 ISRNM共识声明：血液透析治疗期间饮食

英文标题：

Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and Metabolism.

发布机构：

国际肾营养和代谢学会

发布日期：

2017-12-20

简要介绍：

营养状况不良和蛋白质浪费在维持性血液透析患者中很常见，并且与不良结局相关。血液透析治疗期间提供食物，盘餐，快餐和/或口服营养补充可以改善营养状况，也可以减少炎症的发生。本文主要内容涉及血液透析治疗期间有关饮食的相关内容。

 

拓展指南：与血液透析相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 ISRNM共识声明：血液透析治疗期间饮食)] GetToolGuiderByIdResponse(projectId=1, id=267131c0015351d9, title=2017 ISRNM共识声明：血液透析治疗期间饮食, enTitle=Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and Metabolism., guiderFrom=J Ren Nutr. 2018 Jan;28(1):4-12., authorId=null, author=, summary=营养状况不良和蛋白质浪费在维持性血液透析患者中很常见，并且与不良结局相关。血液透析治疗期间提供食物，盘餐，快餐和/或口服营养补充可以改善营养状况，也可以减少炎症的发生。本文主要内容涉及血液透析治疗期间有关饮食的相关内容。 , cover=, journalId=null, articlesId=null, associationId=1567, associationName=国际肾营养和代谢学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Dec 20 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>营养状况不良和蛋白质浪费在维持性血液透析患者中很常见，并且与不良结局相关。血液透析治疗期间提供食物，盘餐，快餐和/或口服营养补充可以改善营养状况，也可以减少炎症的发生。本文主要内容涉及血液透析治疗期间有关饮食的相关内容。 </P> <P> </P>拓展指南：<STRONG>与<FONT color=red>血液透析</FONT>相关指南：</STRONG><BR> <UL> <LI><A title="2017 KSN临床实践指南：中东呼吸综合征血液透析治疗" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=e94e71c001a94396">2017 KSN临床实践指南：中东呼吸综合征血液透析治疗</A> <LI><A title="2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=9032c1c001a910b0">2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）</A> <LI><A title="2012 JSDT指南：糖尿病患者血液透析" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=c78601c00122305b">2012 JSDT指南：糖尿病患者血液透析</A> <LI><A title=血液透析室建设与管理指南 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=160b61c001161a96">血液透析室建设与管理指南</A> <LI><A title="2014 中国血液透析用血管通路专家共识（第1版）" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=afb4b1c00108a9ff">2014 中国血液透析用血管通路专家共识（第1版）</A> 更多信息请点击：<A target=_blank href="//m.capotfarm.com/guideline/list.do?q=%E8%A1%80%E6%B6%B2%E9%80%8F%E6%9E%90">有关血液透析更多指南</A></LI></UL>, tagList=[TagDto(tagId=2080, tagName=血液透析), TagDto(tagId=3229, tagName=饮食)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9679, appHits=538, showAppHits=0, pcHits=6474, showPcHits=3799, likes=142, shares=15, comments=8, approvalStatus=1, publishedTime=Sat Dec 23 22:46:44 CST 2017, publishedTimeString=2017-12-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Dec 23 22:46:44 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 15:23:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 ISRNM共识声明：血液透析治疗期间饮食)])
2017 ISRNM共识声明：血液透析治疗期间饮食
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=954648, encodeId=2164954648d6, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:36 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891073, encodeId=6e408910e378, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201010/e4760e93553d4dd6b0ac9f37e3defe71/6c47966c18d4453ab747ee05ce91a696.jpg, createdBy=35755424622, createdName=ms8000000839225845, createdTime=Sat Oct 10 14:52:54 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891064, encodeId=5a128910647f, content=。。。厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epq0Rc0D2j9EsiaxKUYA7XnrV7DZAgXfxwO9nSXsQ7CzHJXAkULeAC3FQ5FDzRdD7Z73oMGic9icLq4g/132, createdBy=76b65247055, createdName=姜姜5056, createdTime=Sat Oct 10 14:18:15 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330248, encodeId=df9b33024883, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45f12396267, createdName=12344559m56暂无昵称, createdTime=Sun Jul 08 23:11:50 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272037, encodeId=d1182e203703, content=了解一下.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Dec 24 07:57:25 CST 2017, time=2017-12-24, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好，但无法分享，遗憾！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=954648, encodeId=2164954648d6, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:36 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891073, encodeId=6e408910e378, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201010/e4760e93553d4dd6b0ac9f37e3defe71/6c47966c18d4453ab747ee05ce91a696.jpg, createdBy=35755424622, createdName=ms8000000839225845, createdTime=Sat Oct 10 14:52:54 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891064, encodeId=5a128910647f, content=。。。厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epq0Rc0D2j9EsiaxKUYA7XnrV7DZAgXfxwO9nSXsQ7CzHJXAkULeAC3FQ5FDzRdD7Z73oMGic9icLq4g/132, createdBy=76b65247055, createdName=姜姜5056, createdTime=Sat Oct 10 14:18:15 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330248, encodeId=df9b33024883, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45f12396267, createdName=12344559m56暂无昵称, createdTime=Sun Jul 08 23:11:50 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272037, encodeId=d1182e203703, content=了解一下.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Dec 24 07:57:25 CST 2017, time=2017-12-24, status=1, ipAttribution=)]
    2020-10-10 ms8000000839225845

    厉害

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=954648, encodeId=2164954648d6, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:36 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891073, encodeId=6e408910e378, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201010/e4760e93553d4dd6b0ac9f37e3defe71/6c47966c18d4453ab747ee05ce91a696.jpg, createdBy=35755424622, createdName=ms8000000839225845, createdTime=Sat Oct 10 14:52:54 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891064, encodeId=5a128910647f, content=。。。厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epq0Rc0D2j9EsiaxKUYA7XnrV7DZAgXfxwO9nSXsQ7CzHJXAkULeAC3FQ5FDzRdD7Z73oMGic9icLq4g/132, createdBy=76b65247055, createdName=姜姜5056, createdTime=Sat Oct 10 14:18:15 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330248, encodeId=df9b33024883, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45f12396267, createdName=12344559m56暂无昵称, createdTime=Sun Jul 08 23:11:50 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272037, encodeId=d1182e203703, content=了解一下.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Dec 24 07:57:25 CST 2017, time=2017-12-24, status=1, ipAttribution=)]
    2020-10-10 姜姜5056

    。。。厉害

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=954648, encodeId=2164954648d6, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:36 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891073, encodeId=6e408910e378, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201010/e4760e93553d4dd6b0ac9f37e3defe71/6c47966c18d4453ab747ee05ce91a696.jpg, createdBy=35755424622, createdName=ms8000000839225845, createdTime=Sat Oct 10 14:52:54 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891064, encodeId=5a128910647f, content=。。。厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epq0Rc0D2j9EsiaxKUYA7XnrV7DZAgXfxwO9nSXsQ7CzHJXAkULeAC3FQ5FDzRdD7Z73oMGic9icLq4g/132, createdBy=76b65247055, createdName=姜姜5056, createdTime=Sat Oct 10 14:18:15 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330248, encodeId=df9b33024883, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45f12396267, createdName=12344559m56暂无昵称, createdTime=Sun Jul 08 23:11:50 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272037, encodeId=d1182e203703, content=了解一下.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Dec 24 07:57:25 CST 2017, time=2017-12-24, status=1, ipAttribution=)]
    2018-07-08 12344559m56暂无昵称

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=954648, encodeId=2164954648d6, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:36 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891073, encodeId=6e408910e378, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201010/e4760e93553d4dd6b0ac9f37e3defe71/6c47966c18d4453ab747ee05ce91a696.jpg, createdBy=35755424622, createdName=ms8000000839225845, createdTime=Sat Oct 10 14:52:54 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891064, encodeId=5a128910647f, content=。。。厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epq0Rc0D2j9EsiaxKUYA7XnrV7DZAgXfxwO9nSXsQ7CzHJXAkULeAC3FQ5FDzRdD7Z73oMGic9icLq4g/132, createdBy=76b65247055, createdName=姜姜5056, createdTime=Sat Oct 10 14:18:15 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330248, encodeId=df9b33024883, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45f12396267, createdName=12344559m56暂无昵称, createdTime=Sun Jul 08 23:11:50 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272037, encodeId=d1182e203703, content=了解一下.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Dec 24 07:57:25 CST 2017, time=2017-12-24, status=1, ipAttribution=)]
    2017-12-24 天地飞扬

    了解一下.谢谢分享!

    0

相关指南

2017 KSN临床实践指南：中东呼吸综合征血液透析治疗

韩国肾脏病学会(KSN,Korean Society of Nephrology) · 2017-06-01

2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）

暂未更新 · 2017-06-21

2012 JSDT指南：糖尿病患者血液透析

暂未更新 · 2012-03-19

血液透析室建设与管理指南

暂未更新 · 2016-04-20

Baidu
map
Baidu
map
Baidu
map